Search
Fraunhofer Institute for Toxicology and Experimental Medicine
Fraunhofer Institute for Toxicology and Experimental Medicine
Events
Press and media
Career
Contact
Deutsch
Institute
[X]
Institute
Contact persons
Organizational structure
Institute directors
Quality assurance
Our network
Institute chronicles
Board of trustees
Mission statement
40 years of Fraunhofer ITEM
Coronavirus research
Services and Expertise
[X]
Services and Expertise
Drug Development
GMP manufacturing of biopharmaceuticals for clinical trials
Regulatory research and risk assessment in drug development
Preclinical research and testing
Efficacy
Toxicology testing
Clinical trials
Chemical safety and assessment
Bio- and Environmental Analytics
Toxicology testing
Exposure characterization
Regulatory risk assessment
Regulatory research
Translational Biomedical Engineering
Device development and manufacturing processes
Testing and test methods
Regulatory support
Personalized Tumor Therapy
Single-cell analytics
Enrichment, isolation and molecular analysis of rare cells
Decoding single cells
Innovative tumor models
In-vitro and in-vivo drug testing
Advanced preclinical PDX models
Mathematical modeling and bioinformatics
Multi-level disease modeling
Bioinformatics services and consulting
Focuses of Research
[X]
Focuses of Research
Drug Development
Testing of cell-based medicinal products
Controlling antibiotic-resistant pathogens
Precision Cut Lung Slices (PCLS)
Non-invasive breath gas analysis
Development of novel biomarkers for use in clinical trials
Clinical and translational fibrosis research
Imaging of the human lung - visualizing drug efficacy
Chemical Safety and Assessment
Exposure science
Toxicity of fibers, particles, and nanomaterials
Analysis of indoor and workplace air quality
Replacing animal testing
Translational Biomedical Engineering
Innovative approaches for inhaled aerosol therapies
Medical and environmental sensors
Accelerated life cycle testing
Personalized Tumor Therapy
Single-cell technologies
Identification of target structures and therapy prediction
Mathematical modeling of disease processes
Models of treatment and metastasis formation
Lighthouse projects
[X]
Lighthouse projects
German-Australian iCAIR® project: battling infection and resistance
"Phage4Cure": bacteriophages as an approved drug
EU-ToxRisk: How to avoid animal testing
Cluster of Excellence for Immune-Mediated Diseases CIMD
EU project MDOT: Open-innovation test bed to support the certification of medical devices
Mechanisms of metastasis formation
High-Performance Center Medical and Pharmaceutical Engineering
CRC Hannover
Events
[X]
Events
Science Campus@Home 2021
23rd DGRA Annual Congress
ERS International Congress 2021
5th ACTC 2021: Advances in Circulating Tumor Cells
BioEM – The Joint Annual Meeting of the Bioelectromagnetics Society and the European BioElectromagnetics Association
Oral presentation at New and Emerging Technologies 2021
DGK Herztage
Congress of the European Society of Gene and Cell Therapy
2nd International Akademie Fresenius Conference
Models of Lung Disease 2022 - Save the date
Press and media
[X]
Press and media
Newsletter
Annual reports
Publications
Press releases
Reviewing OECD Test Guidelines
Rhinovirus-induced human lung tissue responses mimic COPD and asthma gene signatures
ZeroPM: Zero pollution from persistent, mobile substances
AVATOR - Tracking down aerosols
AVATOR - Indoor Air: How to Eliminate Viruses Effectively
ATMPs – long way to clinical application, but high therapeutic added value
Institute director Prof. Thomas Thum is one of the most cited researchers worldwide
Understanding heart failure and developing innovative therapies
Rapid therapeutic approaches for viral diseases
Machine learning in pediatric intensive-care medicine
REMEDIA project
Project MONO4ERA
Alternative to animal models: Advances in medicine through human-relevant disease models
Better models to shed light on the mutagenicity of N-nitrosamines
News
Thematic Flyers
Career
[X]
Career
Professionals
Postgraduates
Undergraduates
Working at Fraunhofer
Contact
More
Where am I?
English
Focuses of Research
Personalized Tumor Therapy
Focuses of research in Personalized Tumor Therapy
From molecular analysis to personalized therapy
© Fraunhofer ITEM, Ralf Mohr
Models of treatment and metastasis formation
Read more
Single-cell technologies
Next-generation approaches and bioinformatics solutions for single-cell analysis
Multi-level quality control assay
Omics technologies for single cells
Bioinformatics solutions for optimized NGS strategies
Identification and assessment of RNA and DNA biomarkers in cancer
Translating complex biomarkers into molecular diagnostics
Read more
Identification of target structures and therapy prediction
Read More
Mathematical modeling of disease processes
read more
Fraunhofer Institute for Toxicology and Experimental Medicine